MedPath

Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19)

Not Applicable
Recruiting
Conditions
ovel Coronavirus Pneumonia (COVID-19)
Registration Number
ITMCTR2000003225
Lead Sponsor
nion Hospital of Tongji Medical College, Huazhong University of Science and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. novel coronavirus pneumonia diagnostic criteria;
2. age unlimited, male and female unlimited.

Exclusion Criteria

1. not qualified for novel coronavirus pneumonia diagnostic criteria;
2. Pregnant or lactating women who are allergic to the drug;
3. There are factors influencing the observation of curative effect;
4. Those who do not meet the inclusion criteria, fail to use the medicine according to the regulations, fail to determine the curative effect or incomplete data, which affect the judgment of curative effect or safety.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood biochemistry;chest CT;TCM symptom;C-reactive protein;Blood routine;2019-ncov-RNA;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath